Sharks and Rays in Danger

A new report finds that about a quarter of the world’s cartilaginous fish species are at risk of extinction.

Written byJef Akst
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

GuitarfishFLICKR, LASZLO ILYESIn the first global analysis of its kind, an international team of researchers found that of the 1,041 species of cartilaginous fishes (chondrichthyans) investigated, 25 species are critically endangered, 43 are endangered, 113 are vulnerable, and 132 species are “near threatened.” That’s a total of 30 percent of the species analyzed; for 487 of the remaining species, there was insufficient data to classify the threat.

“Overall chondrichthyan extinction risk is substantially higher than for most other vertebrates, and only one-third of species are considered safe,” the authors wrote in their report, published this week (January 21) in eLife.

“Our analysis shows that sharks and their relatives are facing an alarmingly elevated risk of extinction,” coauthor Nicholas Dulvy, a marine ecologist at Simon Fraser University in Burnaby, Canada, and cochair of the International Union for the Conservation of Nature (IUCN) Shark Specialist Group, said in a statement. “In greatest peril are the largest species of rays and sharks, especially those living in shallow water that is accessible to fisheries.”

Dulvy and his coauthors point the finger at human fishing efforts, through which both deliberate and accidental targeting of these species has ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • Jef (an unusual nickname for Jennifer) got her master’s degree from Indiana University in April 2009 studying the mating behavior of seahorses. After four years of diving off the Gulf Coast of Tampa and performing behavioral experiments at the Tennessee Aquarium in Chattanooga, she left research to pursue a career in science writing. As The Scientist's managing editor, Jef edited features and oversaw the production of the TS Digest and quarterly print magazine. In 2022, her feature on uterus transplantation earned first place in the trade category of the Awards for Excellence in Health Care Journalism. She is a member of the National Association of Science Writers.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies